|
Briefing
|
- AI-Based Drug Discovery – London-based Benevolent AI and American startup Insilico Medicine are using artificial intelligence to find potential cure to inhibit spread of 2019 corona virus
- Potential Drug – Benevolent AI identified one drug (janus kinase inhibitor baricitinib), already being used to treat rheumatoid arthritis, can potentially keep virus from infecting the body
- How It Works – Drug can strengthen protein called AAK1 in regulating ACE2, protein on cells of kidney, blood vessels and heart that is susceptible to viral infection
- Clinical Trial – Recommends clinical trial of drug on portion of affected patients as it is safer than other medicines considered
- Other AI Work – Insilico Medicine identified six molecules using AI that can potentially be exploited to create treatment, publishing their work so other medicinal chemists can study further for possible use
- Released Genome – Chinese scientists have sequenced genome of the virus which they shared to international community to discover potential vaccine and treaments
|
|
Accelerator
|
|
|
Sector
|
Healthcare/Health Sciences
|
|
Function
|
Research and Development
|
|
Organization
|
BenevolentAI, Insilico Medicine Inc.
|
|
Source
|
|
|
Original Publication Date
|
February 10, 2020
|
